A carregar...

Subcutaneous apomorphine in the treatment of Parkinson's disease.

Apomorphine a dopamine receptor agonist was given subcutaneously to 57 levodopa treated parkinsonian patients with refractory off-period disabilities for a median period of 16 months. In 30 given intermittent suprathreshold injections the mean number of hours spent in a disabling off state fell from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Frankel, J P, Lees, A J, Kempster, P A, Stern, G M
Formato: Artigo
Idioma:Inglês
Publicado em: 1990
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC487943/
https://ncbi.nlm.nih.gov/pubmed/2313313
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!